Brokerages Set Corteva, Inc. (NYSE:CTVA) Target Price at $88.90

Shares of Corteva, Inc. (NYSE:CTVA) have been given a consensus rating of “Moderate Buy” by the twenty-two research firms that are presently covering the company, MarketBeat.com reports. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $88.9048.

Several equities analysts have recently issued reports on CTVA shares. Berenberg Bank lifted their target price on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Rothschild & Co Redburn boosted their price objective on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Morgan Stanley upped their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Corteva from $90.00 to $100.00 in a report on Monday, May 11th. Finally, UBS Group decreased their price objective on Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 9th.

Corteva Price Performance

CTVA stock opened at $85.83 on Monday. Corteva has a 1 year low of $60.53 and a 1 year high of $87.69. The company has a market cap of $57.40 billion, a P/E ratio of 50.49, a PEG ratio of 2.62 and a beta of 0.56. The firm has a 50-day moving average of $80.42 and a 200 day moving average of $77.61. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period in the previous year, the company posted $1.13 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts forecast that Corteva will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s dividend payout ratio is 42.35%.

Hedge Funds Weigh In On Corteva

Institutional investors have recently bought and sold shares of the stock. William B. Walkup & Associates Inc. grew its position in shares of Corteva by 2.9% during the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after purchasing an additional 126 shares in the last quarter. Wilkerson Advisory Group LLC raised its holdings in Corteva by 6.7% during the 1st quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after buying an additional 133 shares during the period. AdvisorNet Financial Inc lifted its holdings in shares of Corteva by 2.4% in the 1st quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after acquiring an additional 135 shares during the last quarter. First Horizon Corp lifted its stake in Corteva by 9.2% in the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock worth $134,000 after purchasing an additional 135 shares during the last quarter. Finally, Aviance Capital Partners LLC boosted its holdings in Corteva by 1.3% during the 1st quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after acquiring an additional 137 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.